Stay updated on Anitocabtagene-autoleucel in MM Clinical Trial
Sign up to get notified when there's something new on the Anitocabtagene-autoleucel in MM Clinical Trial page.

Latest updates to the Anitocabtagene-autoleucel in MM Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and now includes information about HHS Vulnerability Disclosure.SummaryDifference0.8%
- Check13 days agoChange DetectedThe page has been updated to reflect that it is currently active and not recruiting, with a new revision date of July 16, 2025, replacing the previous revision date of April 15, 2024.SummaryDifference2%
- Check20 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check27 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed. Notably, the information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference5%
- Check34 days agoNo Change Detected
- Check41 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check56 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
Stay in the know with updates to Anitocabtagene-autoleucel in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anitocabtagene-autoleucel in MM Clinical Trial page.